Advertisement

Topics

Cagent Vascular Announces FDA 510(k) Clearance of Next Generation Device for Vessel Dilatation in Peripheral Artery Disease Interventions

10:00 EST 27 Feb 2017 | Businesswire

This article has expired, however you can still download the PDF.
Preview:
Cagent Vascular, a developer of next generation technology for vessel dilatation in cardiovascular disease interventions, announces FDA 510(k) Clearance of its lead product, the Serranatorâ„¢ Alto PTA Serration Balloon Catheter....

Other Sources for this Article

Cagent Vascular
Lauren Pfeiffer +1-610-688-2006
info@cagentvascular.com

NEXT ARTICLE

More From BioPortfolio on "Cagent Vascular Announces FDA 510(k) Clearance of Next Generation Device for Vessel Dilatation in Peripheral Artery Disease Interventions"

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topics

Blood
Blood is a specialized bodily fluid that delivers necessary substances to the body's cells (in animals) – such as nutrients and oxygen – and transports waste products away from those same cells.  In vertebrates, it is composed of blo...

Cardiovascular disease (CVD)
Acute Coronary Syndromes (ACS) Blood Cardiovascular Dialysis Hypertension Stent Stroke Vascular Cardiovascular disease (CVD) includes all the diseases of the heart and circulation including coronary heart disease (angina...